These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 3932700)
1. A new form of dihydrofolate reductase in cancer cells. Iqbal MP; Rothenberg SP J Pak Med Assoc; 1985 Aug; 35(8):237-42. PubMed ID: 3932700 [No Abstract] [Full Text] [Related]
2. Relationship between intracellular dihydrofolate reductase and tightly bound intracellular methotrexate in human neoplastic cells. Bender RA; Makulu DR Biochem Pharmacol; 1976 Apr; 25(8):975-6. PubMed ID: 1063571 [No Abstract] [Full Text] [Related]
3. Competitive protein binding assay of methotrexate. Erlichman C; Donehower RC; Myers CE Methods Enzymol; 1982; 84():447-58. PubMed ID: 7098962 [No Abstract] [Full Text] [Related]
4. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells. Matherly LH; Barlowe CK; Goldman ID Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428 [TBL] [Abstract][Full Text] [Related]
5. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates. Matherly LH; Anderson LA; Goldman ID Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765 [TBL] [Abstract][Full Text] [Related]
6. Presence and properties of dihydrofolate reductases within the genus Trypanosoma. Gutteridge WE; Jaffe JJ; McCormack JJ Br J Pharmacol; 1968 Sep; 34(1):191P-192P. PubMed ID: 4300138 [No Abstract] [Full Text] [Related]
7. Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro. Matherly LH; Fry DW; Goldman ID Cancer Res; 1983 Jun; 43(6):2694-9. PubMed ID: 6189586 [TBL] [Abstract][Full Text] [Related]
8. Dialkyl esters of methotrexate and 3',5'-dichloromethotrexate: synthesis and interaction with aldehyde oxidase and dihydrofolate reductase. Johns DG; Farquhar D; Wolpert MK; Chabner BA; Loo TL Drug Metab Dispos; 1973; 1(3):580-9. PubMed ID: 4149453 [No Abstract] [Full Text] [Related]
9. Methotrexate and folic reductase in human cancer. Hall TC; Roberts D; Kessel DH Eur J Cancer (1965); 1966 Jun; 2(2):135-42. PubMed ID: 5965748 [No Abstract] [Full Text] [Related]
10. Methotrexate. I. Pharmacology and pharmacokinetics. Lippens RJ Am J Pediatr Hematol Oncol; 1984; 6(4):379-95. PubMed ID: 6398629 [TBL] [Abstract][Full Text] [Related]
11. Ligand-binding radioassay for the antifolate compounds: application in patients receiving methotrexate. Rothenberg SP; de Costa M; Iqbal MP Cancer Treat Rep; 1977 Jul; 61(4):575-84. PubMed ID: 884692 [TBL] [Abstract][Full Text] [Related]
12. Rescue effect of exogenous reduced folates on methotrexate polyglutamylation and dihydrofolate reductase activity in L1210 cells. BaliĆska M Acta Biochim Pol; 1988; 35(3):199-205. PubMed ID: 2469275 [TBL] [Abstract][Full Text] [Related]
13. Intrinsic resistance to methotrexate of cultured mammalian cells in relation to the inhibition kinetics of their dihydrololate reductases. Jackson RC; Hart LI; Harrap KR Cancer Res; 1976 Jun; 36(6):1991-7. PubMed ID: 5189 [TBL] [Abstract][Full Text] [Related]
14. Methotrexate binding to dihydrofolate reductase. Roberts GC; Feeney J; Birdsall B; Charlton P; Young D Nature; 1980 Jul; 286(5770):309. PubMed ID: 7402318 [No Abstract] [Full Text] [Related]
15. Models for the binding of methotrexate to Escherichia coli dihydrofolate reductase: direct effect of carboxylate of aspartic acid 27 upon ultraviolet spectrum of methotrexate. Schlegel HB; Poe M; Hoogsteen K Mol Pharmacol; 1981 Jul; 20(1):154-8. PubMed ID: 7027022 [No Abstract] [Full Text] [Related]
16. Interaction of methotrexate polyglutamates and dihydrofolate during leucovorin rescue in a human breast cancer cell line (MCF-7). Allegra CJ; Boarman D Cancer Res; 1990 Jun; 50(12):3574-8. PubMed ID: 1692762 [TBL] [Abstract][Full Text] [Related]
17. A re-evaluation of the competitive protein binding assay for methotrexate binding to dihydrofolate reductase. Drake JC; Allegra CJ; Chabner BA Biochem Pharmacol; 1986 Apr; 35(7):1212-4. PubMed ID: 3964298 [No Abstract] [Full Text] [Related]
18. Effect of folate compounds on the accumulation of methotrexate and the activity of dihydrofolate reductase in liver, kidney and small intestine of the mouse. Rothenberg SP; Iqbal MP; da Costa M J Pharmacol Exp Ther; 1982 Dec; 223(3):631-4. PubMed ID: 6982970 [No Abstract] [Full Text] [Related]
19. Variation of dihydrofolate reductase activity during in vitro and in vivo growth of sublines of L1210 lymphoma. Hillcoat BL J Natl Cancer Inst; 1971 Jan; 46(1):75-80. PubMed ID: 5546195 [No Abstract] [Full Text] [Related]
20. [Molecular mechanisms of cellular resistance to antifolates]. Grzelakowska-Sztabert B Postepy Biochem; 1983; 29(2):167-90. PubMed ID: 6371748 [No Abstract] [Full Text] [Related] [Next] [New Search]